Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:05 PM
Ignite Modification Date:
2025-12-24 @ 12:05 PM
NCT ID:
NCT00253461
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically confirmed ovarian cancer, small cell lung cancer, or other cancers
* Metastatic brain disease
* Eligible for topotecan therapy
* Measurable disease by CT scan and/or MRI
PATIENT CHARACTERISTICS:
Performance status
* ECOG 0-2
Life expectancy
* More than 3 months
Hematopoietic
* WBC ≥ 3,000/mm\^3
* Platelet count ≥ 100,000/mm\^3
Hepatic
* Not specified
Renal
* Creatinine clearance ≥ 50 mL/min
Other
* Not pregnant or nursing
* Adequate end-organ function
* Able to tolerate lying on a radiology table for ≥ 1 hour
* No serious medical or psychiatric illness that would preclude study compliance or giving informed consent
PRIOR CONCURRENT THERAPY: Not specified
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00253461
Study Brief:
Protocol Section:
NCT00253461